Show simple item record

Interim results for phase 1b dose expansion of Mtl-Cebpa in combination with pembrolizumab in patients with advanced solid tumour malignancies

dc.contributor.authorPlummer, R.
dc.contributor.authorSodergren, M.
dc.contributor.authorRyan, B.
dc.contributor.authorTachkov, I.
dc.contributor.authorReebye, V.
dc.contributor.authorMeyer, T.
dc.contributor.authorPinato, D.
dc.contributor.authorSarker, D.
dc.contributor.authorBasu, B.
dc.contributor.authorBlagden, S.
dc.contributor.authorCook, Natalie
dc.contributor.authorEvans, J.
dc.contributor.authorYachnin, J.
dc.contributor.authorChee, C. E.
dc.contributor.authorLi, D. N.
dc.contributor.authorEl-Khoueiry, A.
dc.contributor.authorDiab, M.
dc.contributor.authorHuang, K. W.
dc.contributor.authorD'Alessio, A.
dc.contributor.authorFulgenzi, C.
dc.contributor.authorNoel, M.
dc.contributor.authorKeenan, B.
dc.contributor.authorMahalingam, D.
dc.contributor.authorRaulf, N.
dc.contributor.authorHogson, R.
dc.contributor.authorTan, C. P.
dc.contributor.authorNicholls, J.
dc.contributor.authorAdderkin, A.
dc.contributor.authorVassiliadou, J.
dc.contributor.authorHabib, R.
dc.contributor.authorRossi, J.
dc.contributor.authorHabib, N.
dc.date.accessioned2023-05-17T09:50:55Z
dc.date.available2023-05-17T09:50:55Z
dc.date.issued2022en
dc.identifier.citationPlummer R, Sodergren M, Ryan B, Tachkov I, Reebye V, Meyer T, et al. Interim Results for Phase 1b Dose Expansion of Mtl-Cebpa in Combination with Pembrolizumab in Patients with Advanced Solid Tumour Malignancies. Journal for immunotherapy of cancer. 2022 Nov;10:A888-A9. PubMed PMID: WOS:000919423400804.en
dc.identifier.doi10.1136/jitc-2022-SITC2022.0850en
dc.identifier.urihttp://hdl.handle.net/10541/626281
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1136/jitc-2022-SITC2022.0850en
dc.titleInterim results for phase 1b dose expansion of Mtl-Cebpa in combination with pembrolizumab in patients with advanced solid tumour malignanciesen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentNewcastle University, Newcastle-upon-Tyne,en
dc.identifier.journalJournal for Immunotherapy of Canceren
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record